Ligand · CT8
CT8 · (5Z)-5-(3-bromocyclohexa-2,5-dien-1-ylidene)-N-(pyridin-4-ylmethyl)-1,5-dihydro[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
CT8, (5Z)-5-(3-bromocyclohexa-2,5-dien-1-ylidene)-N-(pyridin-4-ylmethyl)-1,5-dihydro[1,2,4]triazolo[1,5-a]pyrimidin-7-amine (C17 H14 Br N6 +1, 382.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- CT8
- Formula
- C17 H14 Br N6 +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CT8 in 2 structures; the first of them:
- 2C69 · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · CT8 A1299 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 13 more
- 2C69 · Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor · CT8 A1299 · binds ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, LYS33, VAL64 and 13 more
Residues it binds most
ALA 2, ASP 2, GLN 2, GLU 2, GLY 2, LEU 2, LYS 2, PHE 2, VAL 2, ASN 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.